While hsa-miR-3184-5p has not yet been linked to endometriosis, it exerts tumor-suppressive effects in ovarian and breast cancers via modulation of XBP1/AKT/STAT3, FOXP4, and EMT-related signalling [28–30]. Here, FOXP4 is linked to breast cancer.